These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8599273

  • 1. Hypothesis: angiogenesis cytokines in high altitude cerebral oedema.
    Severinghaus JW.
    Acta Anaesthesiol Scand Suppl; 1995; 107():177-8. PubMed ID: 8599273
    [No Abstract] [Full Text] [Related]

  • 2. Angiogenesis-regulating cytokines: activities and interactions.
    Pepper MS, Mandriota SJ, Vassalli JD, Orci L, Montesano R.
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():31-67. PubMed ID: 9053296
    [No Abstract] [Full Text] [Related]

  • 3. [Angiogenic factors in endometriosis].
    Fujimoto J, Tamaya T.
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():65-9. PubMed ID: 11235180
    [No Abstract] [Full Text] [Related]

  • 4. [Tumor angiogenesis].
    Ono M, Kuwano M.
    Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
    [No Abstract] [Full Text] [Related]

  • 5. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL.
    Cancer Res; 1997 Mar 01; 57(5):963-9. PubMed ID: 9041202
    [Abstract] [Full Text] [Related]

  • 6. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis.
    Varner JA.
    EXS; 1997 Mar 01; 79():361-90. PubMed ID: 9002227
    [No Abstract] [Full Text] [Related]

  • 7. Angiogenesis and angiogenesis inhibition: an overview.
    Folkman J.
    EXS; 1997 Mar 01; 79():1-8. PubMed ID: 9002217
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of retinal and choroidal neovascularization.
    D'Amore PA.
    Invest Ophthalmol Vis Sci; 1994 Nov 01; 35(12):3974-9. PubMed ID: 7525506
    [No Abstract] [Full Text] [Related]

  • 9. The role of angiogenic growth factors in breast cancer progression.
    Kern FG, Lippman ME.
    Cancer Metastasis Rev; 1996 Jun 01; 15(2):213-9. PubMed ID: 8842493
    [No Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
    Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M.
    Cancer Res; 1995 Mar 01; 55(5):1189-93. PubMed ID: 7532545
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis?
    Carmeliet P.
    Circ Res; 2000 Aug 04; 87(3):176-8. PubMed ID: 10926865
    [No Abstract] [Full Text] [Related]

  • 12. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium.
    Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK.
    Nat Med; 1996 Sep 04; 2(9):992-7. PubMed ID: 8782456
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis as a biologic and prognostic indicator in human breast carcinoma.
    Engels K, Fox SB, Harris AL.
    EXS; 1997 Sep 04; 79():113-56. PubMed ID: 9002231
    [Abstract] [Full Text] [Related]

  • 14. Angiogenesis in ovarian cancer.
    Brown MR, Blanchette JO, Kohn EC.
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec 04; 14(6):901-18. PubMed ID: 11141340
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW, Adamis AP, Aiello LP.
    Diabetes Metab Rev; 1997 Mar 04; 13(1):37-50. PubMed ID: 9134347
    [No Abstract] [Full Text] [Related]

  • 16. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.
    Brenchley PE.
    Clin Exp Immunol; 2000 Sep 04; 121(3):426-9. PubMed ID: 10971506
    [No Abstract] [Full Text] [Related]

  • 17. Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.
    Pavlakovic H, Havers W, Schweigerer L.
    Angiogenesis; 2001 Sep 04; 4(4):259-62. PubMed ID: 12197470
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001 Sep 04; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C, Ortega N, Bayard F, Plouet J.
    Diabetes Metab; 1996 Jul 04; 22(4):268-73. PubMed ID: 8767174
    [Abstract] [Full Text] [Related]

  • 20. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.
    Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD.
    Cold Spring Harb Symp Quant Biol; 2002 Jul 04; 67():267-73. PubMed ID: 12858549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.